Skip to main content

Table 3 Response to chemoterapy according to clinical characteristics of patients and histological type of tumor

From: The effect of HER2 expression on cisplatin-based chemotherapy in advanced non-small cell lung cancer patients

Patient characteristics

Number of patients

CR+PR+SD

PD

Total Patients

73

61(83.6%)

12 (16.4%)

Sex

   

Male

69

58 (84%)

11 (16%)

Female

4

3(75%)

1 (25%)

Stage

   

Stage IIIB

30

29(96.6%)

1(3.4%)

Stage IV

43

32 (74.4%)

11 (25.6%)

Histopathology

   

Adenocarcinoma

27

21(78%)

6(22%)

Squamous cell (Epidermoid)

34

31(91.2%)

3 (8.8%)

Not otherwise specified (NOS)

12

9 (75%)

3 (25%)